Biotech firm Aspen Neuroscience inks $40m debt financing from SVB

Recently, Aspen Neuroscience raised $147.5 million in Series B financing.

22 December 2022•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.